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It would be hard to imagine providing care for an acutely unwell child without giving them 
supplemental oxygen. This is what we do, what Advanced Paediatric Life Support (PALS) courses 
require; it is also what the public expects of us. Oxygen – in the developed world at least - is seen 
as the panacea that can do no harm and to not give it in a child’s hour of need would be considered 
by some to be negligent. Every television medical drama we are exposed to contains images of 
unwell patients, all with an oxygen mask to signify the degree of severity of their illness. So how did 
this potentially toxic byproduct of photosynthesis become the most commonly administered drug in 
hospitals? Oxygen unlocks the energy stored within the food we eat during the mitochondrial 
production of ATP: ‘oxidative phosphorylation’. If this process ceases, energy failure and hypoxic 
death usually follows. Thus, for decades our focus has been to ensure a steady flow of oxygen from 
the air we breathe to every cell in the body to maintain cellular aerobic respiration. Taking no chances 
and supplying patients with excessive amounts of supplementary oxygen was assumed to be the 
safest strategy. But as we know from other walks of life, too much of a good thing is rarely in our 
best interest. Joseph Priestley eloquently pointed this out to the world when reporting his discovery 
of oxygen: “…for, as a candle burns out much faster in dephlogisticated than in common air, so we 
might, as may be said, live out too fast and the animal powers be too soon exhausted in this pure 
kind of air” [1]. His wise words seem to have been forgotten over the subsequent centuries.  
 
 
Figure 1. Oxidative phosphorylation and the production of mitochondrial reactive oxygen species 
 
Respiration involves the oxidation of fuel substrates and reduction of oxygen during reactions 
catalyzed by the electron transfer system. ATP is generated through the coupling of this process. 
Reactive oxygen species are released from complexes 1 and 3.  C1-4: Complexes 1 to 4; ATP Syn: 
ATP Synthase; CytC: Cytochrome C; O2
*-: Superoxide radical 
 
 
The paradox is that this life-giving gas also has the potential to cause harm.  This requires some 
explanation. A number of key intracellular enzymes that are involved in oxygen metabolism ‘leak’ 
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slightly and as a result release reactive oxygen species (ROS). These molecules play an essential 
role in cell signaling and homeostasis, but in excess they take on a rather more sinister role. One of 
the sites of ROS generation is the inner mitochondrial membrane, emanating from complexes I and 
III during oxidative phosphorylation (figure 1). Cellular partial pressure of oxygen has a significant 
effect on the rate of ROS production, with even modest increases in oxygen partial pressure leading 
to substantial radical release [2]. Natural defence from excessive ROS comes from innate 
antioxidants, primarily enzyme systems that neutralise them to more innocuous molecules. However, 
these systems are easily overwhelmed when ROS production is high, causing an imbalance of 
reduction-oxidation (redox) that leads to oxidative stress. In this state, ROS wreak havoc throughout 
the cell, destroying mitochondrial and cellular DNA, structural proteins, enzymes and lipids. Like the 
inevitability of iron rusting in the presence of oxygen and water, cells struggle to withstand the 
onslaught of ROS when oxygen is in abundance. Altered mitochondrial membrane permeability 
leads to them swelling, becoming dysfunctional and ultimately to autophagy. High levels of oxidative 
stress can result in apoptosis and necrosis, which clinically manifests as organ dysfunction and 
failure.  
 
Current guidance for acutely unwell adults and children advises that oxygen should be titrated to 
achieve an oxygen saturation of 94-98% [3, 4]; however, no evidence-based guidelines exist for 
patients admitted to a critical care unit. Recently a spotlight was focused on the clinical implications 
of oxygen therapy for acutely unwell patients with the publication of Chu et al’s systematic review 
and meta-analysis of oxygen use in acutely unwell adults [5]. In this well-constructed study the 
authors brought together literature from 25 randomised controlled trials (16,037 patients) that 
compared conservative to liberal oxygen administration. Their conclusion was that liberal oxygen 
therapy was associated with a higher mortality than more conservative oxygenation, without 
improving other patient-important outcomes (relative risk 1·21, 95% CI 1·03–1·43). Perhaps this is 
evidence that unrestricted oxygen may cause harm and that we need to reconsider the traditional 
notion that little harm can be done when over oxygenating patients. However, like many meta-
analyses, the information gained from the computations is only as reliable as that which is fed into 
the formula. The studies included in this analysis were highly diverse. Clinical scenarios ranging from 
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emergency surgery to stroke were included. This makes it difficult to determine the validity of the 
results in any individual setting. The nature of the intervention also varied across studies, with some 
comparing selected oxygen concentrations (administered) and others comparing selected arterial 
oxygenation targets (measured).  
 
More importantly though, Chu’s et al.’s meta-analysis does not provide any information about the 
management of acutely unwell children. Only one group relevant to the Archives has been studied 
in detail to date: extreme premature infants (<28 weeks, n=4965 in 5 trials) have been randomised 
to lower (85%-89%) vs higher (91%-95%) oxygen saturation targets. Complex trade-off between 
retinitis of prematurity and necrotising enterocolitis have been observed with no net benefit or harm 
on death or major disability at a corrected age of 18 to 24 months [6]. Risk / benefit profiles from 
extremely premature infants cannot be reasonable extrapolated to older infants or children. Data are 
now emerging in this population. Cunningham et al. randomised 615 ward admissions with 
bronchiolitis to SpO2 target of >94% or >90% and showed this to be equivalent in terms safety and 
clinical effectiveness [7]. The lower target was associated with a clinically significant reduction in 
amount of time participants received oxygen: 27.6 (0 to 68.1) hours vs 5.7 (0 to 32.4) hours hazard 
ratio 1.37 (1.12 to 1.68), p=0.0021 and time to discharge 50.9 (23.1 to 93.4) vs 40.9 (21.8 to 67.3), 
p=0.003. The recent Oxy-PICU trial from the PICSSG group studied 120 emergency admissions to 
PICU receiving mechanical support for respiration and supplemental oxygen. Randomisation was to 
a more restrictive oxygen therapy SpO2 target (88-92%) or standard care (SpO2 >94%). No safety 
concerns were identified and a definitive trial is both feasible and considered a priority by the 
specialty [8]. 
 
A final thing to consider is the mechanisms that may underlie an apparent benefit of a lower than 
normal SpO2. Maybe the explanation is a simple one; that a normal SpO2 is not harmful in itself, but 
attempting to achieve it in hypoxaemic patients may be. In other words, our efforts to improve a 
patient’s arterial oxygenation with a high FIO2 leads oxidative stress in lung the parenchyma, ‘rusting’ 
the lungs and exacerbating the original lung injury. The additional damage caused by positive 
pressure ventilation compounds the issue. Thus, tolerating a lower SpO2 may reduce the magnitude 
 5 
of these interventions and avoid their unnecessary harm. This ‘less is more’ approach to the 
administration of oxygen in acutely unwell patients (both children and adults) clearly requires a great 
deal more research in order for us to fully understand its potential merit in different circumstances. 
Our previous love affair with oxygen is entering a turbulent time. As our knowledge of physiological 
rusting expands we become ever more aware of the harmful side of oxygen. But should we blame 
oxygen radicals and seek to eradicate them or our clumsy use of oxygen and modify this? Whilst the 
results of the recent meta-analysis may tempt us to dial down the oxygen, we should wait until the 
results of on-going and planned studies become available.  
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